Cargando…
DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease
Next-generation sequencing technologies made it possible to assay the effect of rare variants on complex diseases. As an extension of the “common disease-common variant” paradigm, rare variant studies are necessary to get a more complete insight into the genetic architecture of human traits. Associa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524342/ https://www.ncbi.nlm.nih.gov/pubmed/28742119 http://dx.doi.org/10.1371/journal.pone.0179364 |
_version_ | 1783252450242723840 |
---|---|
author | Persyn, Elodie Karakachoff, Matilde Le Scouarnec, Solena Le Clézio, Camille Campion, Dominique Consortium, French Exome Schott, Jean-Jacques Redon, Richard Bellanger, Lise Dina, Christian |
author_facet | Persyn, Elodie Karakachoff, Matilde Le Scouarnec, Solena Le Clézio, Camille Campion, Dominique Consortium, French Exome Schott, Jean-Jacques Redon, Richard Bellanger, Lise Dina, Christian |
author_sort | Persyn, Elodie |
collection | PubMed |
description | Next-generation sequencing technologies made it possible to assay the effect of rare variants on complex diseases. As an extension of the “common disease-common variant” paradigm, rare variant studies are necessary to get a more complete insight into the genetic architecture of human traits. Association studies of these rare variations show new challenges in terms of statistical analysis. Due to their low frequency, rare variants must be tested by groups. This approach is then hindered by the fact that an unknown proportion of the variants could be neutral. The risk level of a rare variation may be determined by its impact but also by its position in the protein sequence. More generally, the molecular mechanisms underlying the disease architecture may involve specific protein domains or inter-genic regulatory regions. While a large variety of methods are optimizing functionality weights for each single marker, few evaluate variant position differences between cases and controls. Here, we propose a test called DoEstRare, which aims to simultaneously detect clusters of disease risk variants and global allele frequency differences in genomic regions. This test estimates, for cases and controls, variant position densities in the genetic region by a kernel method, weighted by a function of allele frequencies. We compared DoEstRare with previously published strategies through simulation studies as well as re-analysis of real datasets. Based on simulation under various scenarios, DoEstRare was the sole to consistently show highest performance, in terms of type I error and power both when variants were clustered or not. DoEstRare was also applied to Brugada syndrome and early-onset Alzheimer’s disease data and provided complementary results to other existing tests. DoEstRare, by integrating variant position information, gives new opportunities to explain disease susceptibility. DoEstRare is implemented in a user-friendly R package. |
format | Online Article Text |
id | pubmed-5524342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55243422017-08-07 DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease Persyn, Elodie Karakachoff, Matilde Le Scouarnec, Solena Le Clézio, Camille Campion, Dominique Consortium, French Exome Schott, Jean-Jacques Redon, Richard Bellanger, Lise Dina, Christian PLoS One Research Article Next-generation sequencing technologies made it possible to assay the effect of rare variants on complex diseases. As an extension of the “common disease-common variant” paradigm, rare variant studies are necessary to get a more complete insight into the genetic architecture of human traits. Association studies of these rare variations show new challenges in terms of statistical analysis. Due to their low frequency, rare variants must be tested by groups. This approach is then hindered by the fact that an unknown proportion of the variants could be neutral. The risk level of a rare variation may be determined by its impact but also by its position in the protein sequence. More generally, the molecular mechanisms underlying the disease architecture may involve specific protein domains or inter-genic regulatory regions. While a large variety of methods are optimizing functionality weights for each single marker, few evaluate variant position differences between cases and controls. Here, we propose a test called DoEstRare, which aims to simultaneously detect clusters of disease risk variants and global allele frequency differences in genomic regions. This test estimates, for cases and controls, variant position densities in the genetic region by a kernel method, weighted by a function of allele frequencies. We compared DoEstRare with previously published strategies through simulation studies as well as re-analysis of real datasets. Based on simulation under various scenarios, DoEstRare was the sole to consistently show highest performance, in terms of type I error and power both when variants were clustered or not. DoEstRare was also applied to Brugada syndrome and early-onset Alzheimer’s disease data and provided complementary results to other existing tests. DoEstRare, by integrating variant position information, gives new opportunities to explain disease susceptibility. DoEstRare is implemented in a user-friendly R package. Public Library of Science 2017-07-24 /pmc/articles/PMC5524342/ /pubmed/28742119 http://dx.doi.org/10.1371/journal.pone.0179364 Text en © 2017 Persyn et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Persyn, Elodie Karakachoff, Matilde Le Scouarnec, Solena Le Clézio, Camille Campion, Dominique Consortium, French Exome Schott, Jean-Jacques Redon, Richard Bellanger, Lise Dina, Christian DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease |
title | DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease |
title_full | DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease |
title_fullStr | DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease |
title_full_unstemmed | DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease |
title_short | DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease |
title_sort | doestrare: a statistical test to identify local enrichments in rare genomic variants associated with disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524342/ https://www.ncbi.nlm.nih.gov/pubmed/28742119 http://dx.doi.org/10.1371/journal.pone.0179364 |
work_keys_str_mv | AT persynelodie doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT karakachoffmatilde doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT lescouarnecsolena doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT lecleziocamille doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT campiondominique doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT consortiumfrenchexome doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT schottjeanjacques doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT redonrichard doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT bellangerlise doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease AT dinachristian doestrareastatisticaltesttoidentifylocalenrichmentsinraregenomicvariantsassociatedwithdisease |